+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Single Lead ECG Equipment Market Size, Share & Trends Analysis Report By End Use (Hospitals & Clinics, Homecare, ASCs), By Indication (Arrhythmia, Syncope), And Segment Forecasts, 2019 - 2025

  • ID: 4751811
  • Report
  • 120 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • AliveCor, Inc.
  • DRE Medical, Inc.
  • Eurocamina
  • Lohman Technologies
  • Longfian Scitech Co.Ltd
  • OMRON Corporation
  • MORE
The global single lead ECG equipment market size is estimated to reach USD 487.59 million by 2025, progressing at a 4.72% CAGR during the forecast period.

Emergence of smartphone and mobile-based cardiac monitoring devices has been revolutionized the market in the past few years. Medical device manufacturers continue to invest in development of these products in order to overcome pitfalls associated with conventional means of cardiac assessment. This is, consequently, fostering the growth of the market.

An Indian company Agatsa Software Pvt. Ltd. introduced credit-card-sized ECG monitors, “Sanket”, which measures ECG in 15 seconds and displays results that can be sent to anyone across the globe via email, social media platforms, or SMS. Such advancements in ECG monitoring devices are anticipated to shape the future of the market over the forecast period.

On the other hand, government bodies are undertaking initiatives for improvement in treatment of cardiac disorders in order to satisfy escalating need for inexpensive and portable devices for regular cardiac monitoring as a preventive step. This, in turn, is expected to positively influence the growth of the market.

Further key findings from the study suggest:
  • Widening base of patients suffering from cardiovascular diseases is expected to augment the single lead portable ECG equipment market
  • The demand for portable ECGs serving home/ambulatory services for risk identification for occurrence of cardiac diseases is projected to grow at a faster pace in the near future
  • The growth of the home/ambulatory segment is supported by continuous improvement in software/algorithms for regular cardiac monitoring
  • Availability of products that can carry out continuous and real time wireless ambulatory patient monitoring is contributing to the growth of the market
  • North America accounted for the largest market share in 2017, owing to well-established healthcare system coupled with rise in prevalence of cardiovascular diseases in the region
  • Presence of several nascent and established participants in the region further drives the R&D and novel product launches in the U.S.
  • Asia Pacific is likely to witness the fastest growth during the forecast period owing to rising patient awareness pertaining to portable technologies as well as increasing healthcare expenditure in developing economies
  • Rise in patient as well as physician awareness and inclination towards medical technology and cloud-based software programs are expected to encourage substantial growth in the region
  • The key players are engaged in launching novel products or algorithms in order to enhance market penetration.


** This report will be delivered within 72 hours after an order is placed.**

Please Note: This report will be delivered within 72 hours of ordering.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AliveCor, Inc.
  • DRE Medical, Inc.
  • Eurocamina
  • Lohman Technologies
  • Longfian Scitech Co.Ltd
  • OMRON Corporation
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Variables Analysis
3.2.1 Market Driver Analysis
3.2.1.1 Advent of technology with respect to mobile ECG
3.2.1.2 High prevalence of atrial fibrillation
3.2.1.3 Government regulations in the favor of remote monitoring devices
3.2.2 Market Restraint Analysis
3.2.2.1 UnsTable reimbursement policies
3.3 Penetration & Growth Prospect Mapping For Indication, 2017
3.4 Business Environment Analysis Tools
3.4.1 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5.1 Porter’s Five Forces Analysis

Chapter 4 Global Single Lead ECG Equipment Market Categorization: Indication Estimates & Trend Analysis
4.1 Global Single Lead ECG Equipment Market : Indication Type Movement Analysis
4.2 Syncope
4.2.1 Global Single Lead ECG Equipment Market for syncope, 2014 - 2025 (USD Million)
4.3 Arrhythmia
4.3.1 Global Single Lead ECG Equipment Market for arrhythmia, 2014 - 2025 (USD Million)
4.3.2 Atrial Fibrillation (AF)
4.3.2.1 Global Single Lead ECG Equipment Market for atrial fibrillation, 2014 - 2025 (USD Million)
4.3.3 Bradycardia
4.3.3.1 Global Single Lead ECG Equipment Market for bradycardia, 2014 - 2025 (USD Million)
4.3.4 Tachycardia
4.3.4.1 Global Single Lead ECG Equipment Market for tachycardia, 2014 - 2025 (USD Million)
4.4 Other Indications
4.4.1 Global Single Lead ECG Equipment Market for other indications, 2014 - 2025 (USD Million)

Chapter 5 Global Single Lead ECG Equipment Market Categorization: End Use Estimates & Trend Analysis
5.1 Global Single Lead ECG Equipment Market : End Use Movement Analysis
5.2 Hospitals & Clinics
5.2.1 Global Single Lead ECG Equipment Market for hospitals & clinics, 2014 - 2025 (USD Million)
5.3 Home-Use
5.3.1 Global Single Lead ECG Equipment Market for home-use, 2014 - 2025 (USD Million)
5.4 Ambulatory Surgical Centres (ASCs)
5.4.1 Global Single Lead ECG Equipment Market for ASCs, 2014 - 2025 (USD Million)

Chapter 6 Global Single Lead ECG Equipment Market Categorization: Regional Estimates & Trend Analysis, by Indication & End Use
6.1 Global Single Lead ECG Equipment Market Share By Region 2017 & 2025
6.2 North America
6.2.1 North America Single Lead ECG Equipment Market , 2014 - 2025 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Single Lead ECG Equipment Market , by indication, 2014 - 2025 (USD Million)
6.2.2.2 U.S. Single Lead ECG Equipment Market , by end use, 2014 - 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Single Lead ECG Equipment Market , by indication, 2014 - 2025 (USD Million)
6.2.3.2 Canada Single Lead ECG Equipment Market , by end use, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 Europe Single Lead ECG Equipment Market , 2014 - 2025 (USD Million)
6.3.2 Germany
6.3.2.1 Germany Single Lead ECG Equipment Market , by indication, 2014 - 2025 (USD Million)
6.3.2.2 Germany Single Lead ECG Equipment Market , by end use, 2014 - 2025 (USD Million)
6.3.3 U.K.
6.3.3.1 U.K. Single Lead ECG Equipment Market , by indication, 2014 - 2025 (USD Million)
6.3.3.2 U.K. Single Lead ECG Equipment Market , by end use, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Single Lead ECG Equipment Market , 2014 - 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Single Lead ECG Equipment Market , by indication, 2014 - 2025 (USD Million)
6.4.2.2 Japan Single Lead ECG Equipment Market , by end use, 2014 - 2025 (USD Million)
6.4.3 China
6.4.3.1 China Single Lead ECG Equipment Market , by indication, 2014 - 2025 (USD Million)
6.4.3.2 China Single Lead ECG Equipment Market , by end use, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America Single Lead ECG Equipment Market , 2014 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Single Lead ECG Equipment Market , by indication, 2014 - 2025 (USD Million)
6.5.2.2 Brazil Single Lead ECG Equipment Market , by end use, 2014 - 2025 (USD Million)
6.6 Middle East & Africa (MEA)
6.6.1 MEA Single Lead ECG Equipment Market , 2014 - 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Single Lead ECG Equipment Market , by indication, 2014 - 2025 (USD Million)
6.6.2.2 South Africa Single Lead ECG Equipment Market , by end use, 2014 - 2025 (USD Million)

Chapter 7 Global Single Lead ECG Equipment Market : Competitive Landscape
7.1 Strategy Framework
7.2 Market Participant Categorization
7.3 Company Profiles
7.3.1 Lohman Technologies
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Ambisea Technology Corp., Ltd
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.3 Eurocamina
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.4 Longfian Scitech Co. Ltd
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.5 Perlong Medical Equipment Co., Ltd
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.6 SUZUKEN CO., LTD
7.3.6.1 Company overview
7.3.6.1.1 Suzuken Company Limited (KENZ)
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.7 VCOMIN TECHNOLOGY LIMITED
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.8 Dimetek Digital Medical Technologies, Ltd
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.9 CONTEC MEDICAL SYSTEMS CO.,LTD
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.10 Tianjin Chase Sun Pharmaceutical Group
7.3.10.1 Company overview
7.3.10.1.1 Beijing Choice Electronic Tech Co., Ltd
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.11 Shenzhen Creative Industry Co., Ltd
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.12 Daily Care BioMedical, Inc.
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.13 REKA Health Pte Ltd
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
7.3.14 DRE Medical, Inc.
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 AliveCor, Inc.
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 OMRON Corporation
7.3.16.1 Company overview
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 Zenicor Medical Systems
7.3.17.1 Company overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.17.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Lohman Technologies
  • Ambisea Technology Corp., Ltd
  • Eurocamina
  • Longfian Scitech Co.Ltd
  • Perlong Medical Equipment Co., Ltd
  • SUZUKEN CO., LTD
  • VCOMIN TECHNOLOGY LIMITED
  • Dimetek Digital Medical Technologies, Ltd
  • CONTEC MEDICAL SYSTEMS CO.,LTD
  • Tianjin Chase Sun Pharmaceutical Group
  • Shenzhen Creative Industry Co., Ltd
  • DailyCare BioMedical, Inc.
  • REKA Health Pte Ltd
  • DRE Medical, Inc.
  • AliveCor, Inc.
  • OMRON Corporation
  • Zenicor Medical Systems
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4751811
Adroll
adroll